Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses
Aims To explore whether circulating matrix metalloproteinase-2 (MMP-2), MMP-9, MMP-9/neutrophil gelatinase-associated lipocalin, MMP-9/tissue inhibitor of metalloproteinase-1 (TIMP-1), MMP-14, TIMP-2 and TIMP-3 were associated with the severity and progression of diabetic retinopathy (DR) in patient...
Saved in:
Main Authors: | Sven Hector, Hans Olav Thulesius, Mona Landin-Olsson, Magnus Hillman, Eva Olga Melin, Maria Thunander |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-08-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001583.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Matrix Metalloproteinases and Risk of Urologic Cancers: A Bidirectional Mendelian Randomization Study
by: BoWen Yang, et al.
Published: (2025-02-01) -
Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
by: Ai Sato, et al.
Published: (2025-03-01) -
Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
by: Doron Yablecovitch, et al.
Published: (2024-09-01) -
Causal role of plasma liposome in diabetic retinopathy: mendelian randomization (MR) study
by: Kai Yin, et al.
Published: (2025-02-01) -
Convolutional neural networks for diabetic retinopathy detection
by: Darwin Patiño-Pérez, et al.
Published: (2025-01-01)